Repligen Corp. Given Buy Rating at Jefferies Group (RGEN)
Repligen Corp. (NASDAQ:RGEN)‘s stock had its “buy” rating restated by research analysts at Jefferies Group in a report released on Tuesday, Analyst Ratings Network reports. They currently have a $17.00 price objective on the stock. Jefferies Group’s target price suggests a potential upside of 24.36% from the company’s current price.
After being very oversold this seems a technical rally based on some excuse.